Mon, June 4, 2012
Sat, June 2, 2012
Fri, June 1, 2012
Thu, May 31, 2012
Wed, May 30, 2012
Tue, May 29, 2012
Mon, May 28, 2012
Sun, May 27, 2012
Sat, May 26, 2012
Fri, May 25, 2012
Thu, May 24, 2012
Wed, May 23, 2012
[ Wed, May 23rd 2012 ]: Market Wire
Moody's Upgrades Mylan
Tue, May 22, 2012

Dynavax to Present at the Jefferies 2012 Global Healthcare Conference


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. jefferies-2012-global-healthcare-conference.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

May 29, 2012 16:00 ET

Dynavax to Present at the Jefferies 2012 Global Healthcare Conference

BERKELEY, CA--(Marketwire - May 29, 2012) - Dynavax Technologies Corporation (NASDAQ: [ DVAX ]) announced today that it plans to present at the Jefferies 2012 Global Healthcare Conference in New York on Tuesday, June 5, at 9:30 a.m. EDT (6:30 a.m. PDT).

Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a corporate overview presentation. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at [ http://investors.dynavax.com/newsevents.cfm ].

About Dynavax

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The Company's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine designed to provide higher and earlier protection with fewer doses than currently licensed vaccines. A U.S. BLA for HEPLISAV has been submitted to the FDA. For more information visit [ www.dynavax.com ].



Publication Contributing Sources